<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03688542</url>
  </required_header>
  <id_info>
    <org_study_id>OLD-NH-QC-DeMo-2017</org_study_id>
    <nct_id>NCT03688542</nct_id>
  </id_info>
  <brief_title>Opportunities and Limits to Deprescribing in Nursing Homes:Quality Circle Deprescribing Module</brief_title>
  <acronym>OLD-NH-QC-DeMo</acronym>
  <official_title>Opportunities and Limits to Deprescribing in Nursing Homes:Quality Circle Deprescribing Module</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Anne Niquille</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Geneva, Switzerland</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Older people residing in nursing homes (NH) are frequently polymedicated and often prescribed
      potentially inappropriate medications. Deprescribing has been proposed as a way to reduce the
      number of drugs they receive and their exposure to harmful treatments.

      The objectives of this study are 1) To evaluate the effect of a deprescribing-specific
      interdisciplinary quality circle module on the use of potentially inappropriate medication in
      nursing-home residents. 2) To determine the effective strategies to reach and implement
      deprescribing consensus resulting of said quality circle module.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">September 25, 2017</start_date>
  <completion_date type="Anticipated">June 2020</completion_date>
  <primary_completion_date type="Anticipated">June 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in the proportion of PIMs use</measure>
    <time_frame>12 months</time_frame>
    <description>The primary outcome is the change at 12 months, relative to baseline, in the proportion of Potentially Inappropriate medication (PIMs) used in the NHs relative to their total drug consumption</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in the number of potentially inappropriate Defined Daily Doses (DDDs) per average resident and per day</measure>
    <time_frame>12 months</time_frame>
    <description>Sum of Defined Daily Doses identified as potentially inappropriate, divided by the total number of days spent in the NH</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Difference in proportion of probably inappropriate galenic units and of possibly inappropriate galenic units</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Difference in proportion of probably inappropriate Defined Daily Doses (DDDs) and of possibly inappropriate DDDs:</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of hospital days</measure>
    <time_frame>12 months</time_frame>
    <description>The number of days spent in the hospital by residents in the nursing home</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mortality rate</measure>
    <time_frame>12 months</time_frame>
    <description>The proportion of residents of the nursing home having died</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of falls per mean resident and per month</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of restraints measures per mean resident and per month</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">62</enrollment>
  <condition>Polypharmacy</condition>
  <condition>Inappropriate Prescribing</condition>
  <arm_group>
    <arm_group_label>Intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Nursing Homes allocated to the Intervention arm will enact the Quality Circle Deprescribing Module and create a local deprescribing consensus and implementation strategy.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Nursing Homes allocated to the Control arm will not enact the intervention.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Quality Circle Deprescribing Module</intervention_name>
    <description>The Quality Circle Deprescribing Module consist of a discussion bringing together nurses, physicians and responsible pharmacist to create a local deprescribing consensus for frequently used drug classes, as well as implementation strategies for the consensus..</description>
    <arm_group_label>Intervention</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Nursing homes taking part in the study must have

          -  a geriatric of psycho-geriatric mission;

          -  been part of their cantonal pharmaceutical assistance program for at least a year.

        Exclusion Criteria:

          -  None
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Olivier Bugnon, Prof</last_name>
    <role>Study Director</role>
    <affiliation>University of Geneva</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Centre de Pharamacie Communautaire</name>
      <address>
        <city>Lausanne</city>
        <state>Vaud</state>
        <zip>1011</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <link>
    <url>http://www.nfp74.ch/en/projects/in-patient-care/project-bugnon</url>
    <description>Website of funding body</description>
  </link>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>September 26, 2018</study_first_submitted>
  <study_first_submitted_qc>September 26, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">September 28, 2018</study_first_posted>
  <last_update_submitted>March 31, 2020</last_update_submitted>
  <last_update_submitted_qc>March 31, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 3, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>University of Geneva, Switzerland</investigator_affiliation>
    <investigator_full_name>Anne Niquille</investigator_full_name>
    <investigator_title>Dr</investigator_title>
  </responsible_party>
  <keyword>Deprescribing</keyword>
  <keyword>Inappropriate Medication</keyword>
  <keyword>Nursing Homes</keyword>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>February 5, 2020</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/42/NCT03688542/Prot_001.pdf</document_url>
    </provided_document>
  </provided_document_section>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

